With the surge of precision medicine, scientists are increasingly in need of human biospecimens that match specific patient and specimen criteria
The agreement will drive medical innovation by making human biospecimens and associated data from within the GLHC network available to research program
With the promise of personalized medicine, the drug and diagnostic industries are booming,as are academic medical research programs.
New approaches promise financial and environmental cost savings while addressing the challenge of increased bio-specimen collection
CURRENT ISSUE - January/February 2026
Applying the Six Cs Helps Labs Deliver Results Stakeholders Can Rely On